152 related articles for article (PubMed ID: 9677465)
1. Oral Anticoagulation in patients with gynecological cancer and radiotherapy: a retrospective analysis of 132 patients.
Graf AH; Graf B; Brandis MG; Kogelnik HD; Staudach A; Traun H
Anticancer Res; 1998; 18(3B):2047-51. PubMed ID: 9677465
[TBL] [Abstract][Full Text] [Related]
2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
4. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
5. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
6. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
Torn M; van der Meer FJ; Rosendaal FR
Arch Intern Med; 2004 Mar; 164(6):668-73. PubMed ID: 15037497
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary embolism after major abdominal surgery in gynecologic oncology.
Martino MA; Borges E; Williamson E; Siegfried S; Cantor AB; Lancaster J; Roberts WS; Hoffman MS
Obstet Gynecol; 2006 Mar; 107(3):666-71. PubMed ID: 16507939
[TBL] [Abstract][Full Text] [Related]
9. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
[TBL] [Abstract][Full Text] [Related]
10. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group.
Di Carlo V; Agnelli G; Prandoni P; Coccheri S; Gensini GF; Gianese F; Mannucci PM
Thromb Haemost; 1999 Jul; 82(1):30-4. PubMed ID: 10456450
[TBL] [Abstract][Full Text] [Related]
11. Risks of oral anticoagulant therapy with increasing age.
Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis.
Clarke-Pearson DL; Jelovsek FR; Creasman WT
Obstet Gynecol; 1983 Jan; 61(1):87-94. PubMed ID: 6823353
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of dalteparin versus unfractionated heparin as venous thromboembolism prophylaxis in malignant gynecologic surgery.
Wade WE; Spruill WJ
Am J Ther; 2008; 15(6):512-5. PubMed ID: 19127133
[TBL] [Abstract][Full Text] [Related]
14. Prevention of thromboembolism.
Geelhoed GW
Am Fam Physician; 1979 Mar; 19(3):147-53. PubMed ID: 425867
[TBL] [Abstract][Full Text] [Related]
15. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
16. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
18. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
[TBL] [Abstract][Full Text] [Related]
19. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism and cancer.
Rahr HB; Sørensen JV
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):451-60. PubMed ID: 1420820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
